Clinical trial · Interventional
This is a Randomized Study of Early Involvement of Palliative Care Along Side Standard Treatment Versus Standard Treatment Alone in Newly Diagnosed Patients With Advanced or Metastatic Soft Tissue Sarcoma (SARQUALITY)
Integrating Early Palliative Care in Advanced SARcoma Patients for Enhanced QUALITY of Life: the SARQUALITY Study
NCT06805669CI-TRIAL-00085386SARQUALITYrecruitingN/AClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
The goal of this study is to learn whether early referral to palliative care improves quality of life for patients with advanced sarcoma. Participants enrolled in this study will complete quality of life questionnaires before starting their treatment, and every 6 weeks for 24 weeks.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Sarcoma | Sarcoma | ONTOLOGY_EXACT | 0.98 |
Interventions
Interventions (2)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Early referral to palliative care | Other | — | UNRESOLVED |
| Standard Treatment | Other | — | UNRESOLVED |
Design
Arms and outcomes
Arms (2)
- type
- EXPERIMENTAL
- label
- Early Referral to Palliative Care
- interventionNames
- Other: Early referral to palliative care
- type
- OTHER
- label
- Standard Treatment
- interventionNames
- Other: Standard Treatment
Primary outcomes (1)
- measure
- To determine the difference of Health Related Quality of Life (HRQoL) for sarcoma patients who receive early palliative care versus not
- timeFrame
- From enrollment/baseline to 12 weeks
- description
- HRQoL will be assessed using ESAS-r (Edmonton Symptom Assessment System - revised) and EORTC QLQ-C30 (European Organization for the Research and Treatment of Cancer Quality of Life Questionnaire C-30).
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: * Signed written and voluntary informed consent. * Have histologically documented advanced sarcoma, either locally advanced not amenable to curative treatment, or metastatic. * Age ≥ 18 years. * Have not received any previous systemic treatment with palliative intent for advanced sarcoma. * Performance status of 0-2 on the Eastern Cooperative Oncology Group (ECOG) performance scale. * Life expectancy \> 6 months. * Willing/able to complete questionnaires. Exclusion Criteria: * Clinical evidence of cognitive impairment that would preclude the ability to provide informed consent and complete questionnaires, at investigator´s discretion. * Patient in need of urgent home support services or symptom management through a palliative care team. * Patient is being actively followed by a palliative care physician. * Active psychiatric disorder or drug abuse. * Insufficient English literacy to complete questionnaires.
References
Publications (0)
Data not yet available
No reference posted for this study.